Investors have bought into Receptor Life Sciences’ vision of treating acute anxiety disorders using a dry powder inhaled cannabidiol (CBD). With $9.7 million in fresh …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
